Similar articles

• Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.

  Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras Ad AD, Kusamura S. Deraco M, et al. Ann Surg Oncol. 2006 Feb;13(2):229-37. doi: 10.1245/ASO.2006.03.045. Epub 2006 Jan 18. Ann Surg Oncol. 2006. PMID: 16444562 Clinical Trial.
• [Peritoneal mesothelioma. A case report].

  Catania V, Bonaccorso R, Fraggetta F, Vecchio S, Grasso F, Cammisuli F, Minutolo V, Cavallaro V. Catania V, et al. Ann Ital Chir. 1996 Sep-Oct;67(5):697-701. Ann Ital Chir. 1996. PMID: 9036830 Italian.
• Local-regional approach to diffuse malignant peritoneal mesothelioma.

  Sugarbaker PH. Sugarbaker PH. Gastroenterol Clin Biol. 2007 Oct;31(10):780-1. doi: 10.1016/s0399-8320(07)73963-5. Gastroenterol Clin Biol. 2007. PMID: 18166852 No abstract available.
• [Updated treatment of peritoneal carcinomas: a review].

  Deraco M, Laterza B, Kusamura S, Baratti D. Deraco M, et al. Minerva Chir. 2007 Dec;62(6):459-76. Minerva Chir. 2007. PMID: 18091656 Review. Italian.
• Malignant transformation of "benign" cystic mesothelioma of the peritoneum.

  González-Moreno S, Yan H, Alcorn KW, Sugarbaker PH. González-Moreno S, et al. J Surg Oncol. 2002 Apr;79(4):243-51. doi: 10.1002/jso.10081. J Surg Oncol. 2002. PMID: 11920782 Review.